SS Innovations International, Inc. reported $52M of revenue over the trailing twelve months, +90% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $52M (to Q2 2026). Net income: −$12M, trailing twelve months to Q2 2026. Free cash flow: −$18M, trailing twelve months to Q2 2026. Operating margin: −17%, trailing twelve months to Q2 2026.

SSIISS Innovations International, Inc.

Healthcare

$2.69-61% 1Y

$2.69

$2.6952 weeks$9.98

Latest close: a new 52-week lowOct 8, 2026what changed →

SSII as reported

SS Innovations International, Inc. reported $52M of revenue over the trailing twelve months, +90% on the year before. 10 reported series are charted on this page, each one as filed.

$52M

Revenue, trailing twelve months · to Q2 2026 · +90% against the twelve months before

Net income: −$12M
Net income · +12% year on year · trailing twelve months to Q2 2026
Free cash flow: −$18M
Free cash flow · −0.89% year on year · trailing twelve months to Q2 2026
Operating margin: −17%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SSII, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$52M	+90%	Q2 2026
Net income	−$12M	+12%	Q2 2026
EPS	−$0.06	0.00%	Q2 2026
Gross margin	48%	n/a	Q2 2026
Operating margin	−17%	n/a	Q2 2026
Net margin	−24%	n/a	Q2 2026
ROE	−26%	n/a	Q2 2026
ROA	−14%	n/a	Q2 2026
ROIC	−110%	n/a	Q4 2024 · 6 quarters behind
Free cash flow	−$18M	−0.89%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.